HPV penile lesions are growths on the penis caused by human papillomavirus, ranging from common genital warts to precancerous changes in the skin known as penile intraepithelial neoplasia (PeIN). They typically appear as painless bumps, patches, or flat discolorations, and their treatment depends on the type, size, and location of the lesion. Most penile HPV infections clear on their own within months, but visible lesions usually need active treatment, whether that means topical creams, freezing, surgical removal, or a combination.
What These Lesions Actually Look Like
Penile warts are the most recognizable HPV lesion. They usually show up as painless raised bumps or flat patches on the shaft, glans, foreskin, or around the base of the penis. Their texture and shape vary quite a bit. Some are smooth and dome-shaped, others are rough and cauliflower-like, and still others appear as thin finger-like projections. They can also be flat or slightly raised plaques that blend more closely with surrounding skin.1PubMed Central. Penile warts: an update on their evaluation and management Most are flesh-colored, though they sometimes look darker or reddish depending on skin tone.
Precancerous lesions, called PeIN, are a different animal. They tend to appear as persistent reddish-brown or whitish patches, sometimes with a velvety or scaly surface. Unlike warts, PeIN lesions are not always obviously “raised” and can be mistaken for eczema, a fungal infection, or other inflammatory skin conditions. This is part of what makes them concerning: because they don’t always look alarming, they can go unnoticed or misdiagnosed for a long time. Any non-healing or ulcerating lesion on the penis warrants a biopsy to rule out something more serious.2Advances in Anatomic Pathology. Intraepithelial Penile Lesions
Low-Risk Versus High-Risk HPV Types
Not all HPV types behave the same way, and the distinction matters for understanding what a penile lesion means. The strains responsible for the classic raised genital wart are almost always low-risk types, particularly HPV 6 and HPV 11. These strains cause cosmetically bothersome growths but carry very little cancer risk. High-risk types, especially HPV 16 and HPV 18, are the ones linked to precancerous changes and, eventually, penile cancer.
The two categories overlap more than people expect. A study examining penile lesions found that high-risk HPV types appeared in roughly 8% of classic pointed warts but in more than half of flat (macular) lesions, and there was a strong correlation between the presence of high-risk types and abnormal cell changes under the microscope.3PubMed Central. The prevalence of “high-risk” HPV types in penile condyloma-like lesions: correlation between HPV type and morphology The practical takeaway is that flat or discolored patches on the penis deserve more scrutiny than a typical bumpy wart, because they are more likely to harbor the virus types that can lead to precancerous changes.
HPV-associated PeIN accounts for the majority of precancerous penile lesions in North America and Europe. It tests positive for p16, a protein marker that flags high-risk HPV involvement. A separate, HPV-independent form of PeIN also exists, more common in populations with high rates of phimosis and chronic inflammatory conditions like lichen sclerosus.2Advances in Anatomic Pathology. Intraepithelial Penile Lesions This means that not every precancerous penile lesion is caused by HPV, though the HPV-driven type is the most common one in Western countries.
How Doctors Diagnose Penile HPV Lesions
In most cases, a clinician can identify a genital wart just by looking at it. The classic raised, cauliflower-textured growth on the penis doesn’t usually require lab confirmation. But when the diagnosis is uncertain, or when a lesion looks atypical, additional tools come into play.
Dermoscopy, which involves examining the skin through a magnifying lens with polarized light, has proven highly accurate for confirming genital warts. One study found dermoscopy achieved 100% sensitivity and specificity in identifying anogenital warts.4PubMed Central. Correlation between Acetowhite Examination, Dermoscopy, and Histopathology in Patients with Anogenital Warts The acetic acid (vinegar) test, where dilute acetic acid is applied to the skin and HPV-infected areas turn white, is also used but has limitations. It picks up visible warts reasonably well but struggles to identify subclinical infection and produces false positives from inflammation or other conditions.5PubMed. The acetowhite test in genital human papillomavirus infection in men: what does it add? When acetic acid results were checked against tissue biopsies, the positive predictive value was around 72%, meaning roughly a quarter of “positive” spots turned out to be something other than HPV.6Sexually Transmitted Infections. The acetic acid test in evaluation of subclinical genital papillomavirus infection
Biopsy remains the gold standard when there is any suspicion of precancerous or cancerous changes. If a lesion is persistent, changes color, ulcerates, or doesn’t respond to standard wart treatment, a tissue sample sent to pathology can determine whether dysplasia or PeIN is present. This step matters because visual inspection alone cannot reliably distinguish a benign wart from something more worrisome.
The Challenge of HPV Testing in Men
Unlike women, who have well-established cervical HPV screening programs, men have no approved routine HPV test and no standardized screening guidelines. This remains a gap in clinical practice.7PubMed Central. The necessity and challenges of human papillomavirus testing for men When HPV DNA testing is performed in men, usually in research settings or specialized clinics, the choice of sampling site matters considerably. One study found that no single sampling location picked up all HPV types in a given patient. A swab of the wart itself detected about half of a patient’s HPV types, and combining multiple sites (wart, penile shaft, coronal sulcus, scrotum, and external urethral meatus) was needed to approach full detection.8PubMed. Evaluation of the optimal sampling approach for HPV genotyping in circumcised heterosexual men with genital warts
For most men with visible penile warts, formal HPV typing isn’t necessary because it doesn’t change the treatment plan. But in cases of suspected PeIN or when cancer risk needs to be assessed, knowing whether high-risk types are involved can guide how aggressively the lesion is monitored or treated.
How Long Penile HPV Infections Last
Most penile HPV infections resolve without treatment. In men, the median time to clearance of any HPV infection is about six months, and three-quarters of infections clear within a year.9PubMed Central. Epidemiology and pathology of HPV disease in males This refers to the underlying viral infection detectable by DNA testing, not necessarily to visible warts. A wart that has already formed may persist even as the virus itself is being cleared by the immune system, which is part of why treatment is directed at the lesion rather than the virus.
Clearance rates differ by HPV type. In a study of young men, penile HPV 18 cleared fastest, while HPV 6 and HPV 11 cleared more slowly.10PubMed Central. Clearance of anal and penile HPV 6, 11, 16, and 18 DNA and antibodies among adolescent men who have sex with men (HYPER): An observational cohort study High-risk HPV types tend to take longer to clear than low-risk types, which matters because prolonged infection with high-risk strains is what drives the progression toward precancerous changes.11Infection and Drug Resistance. Genital HPV Prevalence, Follow-Up and Persistence in Males and HPV Concordance Between Heterosexual Couples in Wenzhou, China Having a partner who also carries HPV extends clearance time, likely because of ongoing re-exposure.
Treating Genital Warts on the Penis
Treatment for penile warts falls into two broad camps: topical therapies you apply at home and in-office procedures that physically destroy the lesion. Both work, both have downsides, and recurrence is common regardless of the method used.
Topical Therapies
The two most commonly prescribed at-home treatments are imiquimod cream and sinecatechins (green tea extract) ointment. Imiquimod works by stimulating the immune system to attack the virus locally. You apply it to the warts several times per week for weeks to months, which demands patience. Sinecatechins ointment is applied more frequently (usually three times daily) but works through a different mechanism. Both suffer from the same problems: compliance is hard to maintain over a long treatment course, and recurrence rates are high.12PubMed Central. Genital warts treatment: Beyond imiquimod
Trichloroacetic acid (TCA), a chemical applied by a clinician in the office, is another widely used option. It works by chemically destroying the wart tissue on contact. In head-to-head comparisons with cryotherapy (freezing), TCA performed similarly: one trial found wart clearance in about 81% of TCA-treated patients versus 88% for cryotherapy, with early recurrence rates of roughly 36% and 39% respectively.13PubMed Central. Cryotherapy compared with trichloroacetic acid in treating genital warts Another randomized trial comparing liquid nitrogen to TCA for penile warts specifically found that about 75% of participants achieved complete clearance within three sessions regardless of method.14Surgical & cosmetic dermatology. Cryosurgery with liquid nitrogen versus trichloroacetic acid in the treatment of human papillomavirus (HPV) penile wart: a randomized controlled trial
Ablative and Surgical Procedures
Cryotherapy (freezing with liquid nitrogen), electrosurgery (burning with an electric current), CO2 laser ablation, and surgical excision are all used for penile warts. A systematic review found that electrosurgery achieved up to 100% initial clearance with a one-year recurrence rate of about 15%, while TCA chemical cautery reached up to 94% clearance with a higher recurrence rate around 28%.15PubMed Central. The Effectiveness of Chemical Cautery and Electrosurgery on Anogenital Wart: Systematic Review Laser therapy requires local anesthesia but can penetrate deeper than cryotherapy, making it useful for thick or extensive warts.16PubMed Central. CO 2 Laser therapy versus cryotherapy in treatment of genital warts; a Randomized Controlled Trial
The honest picture is that surgical approaches generally achieve similar clearance rates to each other, but all carry high recurrence rates.17PubMed. Critical appraisal of commonly used treatment for genital warts Recurrence doesn’t mean treatment failed; it usually means the virus persisted in nearby skin that looked normal at the time of treatment. Multiple treatment sessions are the norm rather than the exception.
Treating Precancerous Penile Lesions
When a biopsy confirms PeIN rather than a simple wart, the treatment approach shifts. The goal becomes complete eradication of the abnormal cells to prevent progression to invasive penile cancer. The two most commonly used topical options are 5-fluorouracil (5-FU) cream and imiquimod, with reported complete response rates of up to 57%.18PubMed Central. Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity These are the same drugs used for superficial skin cancers elsewhere on the body, applied directly to the lesion over several weeks.
Photodynamic therapy (PDT), which involves applying a light-sensitizing agent to the skin and then exposing it to a specific wavelength of light, has also been studied. In one series of ten patients, seven responded initially, with four remaining clear over a follow-up averaging nearly three years after an average of about four treatment sessions. No patient in that series developed invasive cancer.19Acta Dermato-Venereologica. Penile intraepithelial neoplasia: results of photodynamic therapy Some clinicians have combined PDT with circumcision, particularly for men with a long foreskin where the lesion may be difficult to access or where phimosis contributes to the problem.20PubMed. Photodynamic therapy combined with circumcision for the treatment of penile intraepithelial neoplasia Evidence for PeIN treatments overall remains thin, with no randomized controlled trials yet completed, so treatment decisions tend to be individualized based on lesion size, location, and patient factors.
How HIV Changes the Picture
HIV infection substantially alters how the body handles HPV. Men living with HIV acquire high-risk penile HPV infections at a higher rate and carry multiple HPV types more frequently than HIV-negative men.21Southern African Journal of HIV Medicine. Human papillomavirus infection and disease in men: Impact of HIV In a cohort study of men who have sex with men, the incidence of high-risk HPV at the penis was about 40% higher in HIV-positive participants.22AIDS. The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM
Separate research has found that high-risk HPV types in particular are detected more often in penile samples from HIV-positive men, while low-risk types predominate in HIV-negative men. Multiple concurrent HPV infections are also significantly more common in HIV-positive individuals.23PubMed. Persistence and clearance of HPV from the penis of men infected and non-infected with HIV The clinical consequence is straightforward: men with HIV are more likely to develop HPV-related penile lesions, those lesions are more likely to involve dangerous strains, and closer monitoring is warranted.
Condoms, Circumcision, and Risk Reduction
Condoms reduce but do not eliminate penile HPV transmission, because the virus can infect skin that a condom doesn’t cover. Still, consistent use makes a real difference. In a large multinational study, men who always used condoms with non-steady partners acquired HPV at about half the rate of men who never used them, and they cleared oncogenic HPV infections about 30% faster.24PubMed Central. Consistent Condom Use Reduces the Genital Human Papillomavirus Burden Among High-Risk Men: The HPV Infection in Men Study
Circumcision has a stronger and more consistent protective effect on glans HPV specifically. A randomized controlled trial in Kenya found that circumcised men had about 40% lower incidence of new HPV infection and nearly double the rate of clearing existing infections compared to uncircumcised men, though the benefit was concentrated on the glans rather than the shaft.25PubMed Central. Male circumcision reduces penile HPV incidence and persistence: a randomized controlled trial in Kenya A large meta-analysis pooling data from 32 studies confirmed the pattern: circumcised men had roughly half the odds of prevalent glans HPV infection and cleared infections faster.26PubMed. Association between male circumcision and human papillomavirus infection in males and females: a systematic review, meta-analysis, and meta-regression Another randomized trial reported that the prevalence of high-risk HPV types was about 18% in the circumcision group versus 28% in the control group.27PubMed Central. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis
The biological explanation is that the inner foreskin is especially vulnerable to HPV because it has a thinner epithelium and a higher density of target cells. Removing it reduces the surface area where the virus can take hold. This doesn’t mean circumcision prevents all penile HPV, especially on the shaft, but it consistently lowers the burden on the glans and foreskin area, which is where PeIN and penile cancer most commonly develop.
HPV Vaccination and Penile Lesions
HPV vaccines (the current standard is Gardasil 9) protect against nine HPV types, including the two low-risk types that cause most warts (6 and 11) and the high-risk types most associated with cancer (16 and 18, among others). The vaccine is most effective when given before someone has been exposed to HPV, which is why guidelines recommend vaccination starting around age 11 or 12. Catch-up vaccination is available through age 26 for most people and up to 45 in some cases after discussion with a clinician.
The evidence for the vaccine’s effectiveness against cervical disease in women is overwhelming. For penile disease specifically, direct proof is thinner. No large trial has been designed with penile cancer or PeIN as a primary endpoint, in part because penile cancer is rare enough that such a trial would require enormous numbers of participants and decades of follow-up. The reasoning behind vaccinating boys and men rests on the known connection between HPV 16/18 and penile cancer, combined with strong vaccine efficacy against these types at other anatomical sites. Researchers have acknowledged that further study is needed to confirm how well vaccination programs translate into reduced rates of penile cancer and PeIN specifically.28PubMed. HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions? What we do know is that the vaccine dramatically reduces genital wart incidence in vaccinated populations, which is the most common visible consequence of penile HPV.
When to Talk to a Partner
An HPV diagnosis, especially one involving visible lesions, inevitably raises questions about transmission to sexual partners. The reality is that HPV is extraordinarily common and most sexually active people will encounter it at some point. Visible warts are contagious, and transmission can happen even when no lesion is present, through skin-to-skin contact. There is no approved HPV test for routine male screening, so a man with a cleared infection has no reliable way to prove he is “HPV-free.” This creates uncertainty that can be psychologically burdensome for both partners.
Partner notification and counseling are recommended, though the specifics of how couples should manage the situation depend on the context. If warts are currently present, avoiding direct contact with the lesions and using condoms reduces but does not eliminate transmission risk. If one partner has been treated and the lesions have resolved, the residual transmission risk drops significantly but is not zero. HPV concordance between couples is common: in heterosexual pairs, when one partner carries HPV, the other frequently does too.29PubMed Central. The challenging approach to the management of male partners of HPV-positive women Vaccination of the uninfected partner, if they haven’t been vaccinated, is one of the most practical steps a couple can take.
Why Recurrence Happens and What to Expect
If there is one theme that runs through every treatment discussion for HPV penile lesions, it is recurrence. Warts come back in roughly a quarter to a third of treated patients within the first year, regardless of whether they were frozen, burned, lasered, or treated with creams. This is not a failure of treatment so much as a limitation of what treatment can do: every method destroys the visible lesion but none reliably eliminates the virus from surrounding skin that appears normal. Residual HPV DNA in those cells can reactivate and produce new growths, particularly if the immune system is under stress.
The good news is that recurrences tend to get smaller and less frequent over time as the immune system gradually gains the upper hand. Most men who deal with recurrent penile warts eventually reach a point where new lesions stop appearing, typically within one to two years. For PeIN, the stakes are higher and long-term follow-up is important even after successful treatment, because the progression to invasive cancer, while uncommon, is the outcome that monitoring aims to catch early. Regular self-examination and scheduled clinical follow-up are the most practical tools for staying ahead of any recurrence.